Eyestem

Series-A
eyestem.com Biotech & Healthcare
Total Funding $6.4M
Latest Round $6.4M Series-A
Last Announced Aug 8, 2022
Investors Undisclosed
Decision Makers 2 Available

About Eyestem

Developing allogeneic cell therapies for degenerative diseases of the eye

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website eyestem.com
Domain Registered Date Undisclosed

Social & Network Presence

LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $6,400,000 · Series-A

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Eyestem.

Funding History

1 Round
Series-A equity · Aug 8, 2022

Founders & Leadership

3

Jogin Desai

Founder

Work email & phone locked Unlock →

Rajani Battu

Co-Founder

Work email & phone locked Unlock →

Rajarshi Pal

Co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts